Squamous cell carcinoma of the equine stomach.

This case series describes seven horses aged six years or older with a malignant stomach tumor called squamous cell carcinoma, outlining how they presented clinically and what was found on pathological examination. Weight loss and poor body condition were the dominant signs, metastases were common, and the authors discuss why diagnosing this cancer is challenging and how it can be approached.

What the study asked and why it matters

• Objective: to describe the clinical signs and pathological features of equine gastric squamous cell carcinoma (SCC) and to discuss practical diagnostic challenges and options.
• Importance: gastric SCC is uncommon but often advanced at detection; signs are vague (notably chronic weight loss), so cases are frequently missed until metastasis has occurred, which worsens prognosis and limits treatment.

Study design and population

• Design: descriptive case series summarizing both clinical and pathological observations.
• Population: seven horses, all at least six years old, evaluated for chronic illness marked by weight and condition loss.
• Data sources: clinical records and pathological examination (including necropsy in many such reports), allowing correlation between presenting signs and tumor distribution.
• Scope: no control group or interventions; emphasis on characterization and diagnostic considerations rather than outcomes of therapy.

Main findings reported in the abstract

• Primary complaints: progressive loss of weight and body condition were the dominant presenting issues across cases.
• Age: all affected horses were mature (≥6 years), indicating disease tends to appear in adult horses rather than foals or very young animals.
• Metastatic behavior: metastases had often developed by the time of evaluation or postmortem examination, underscoring the tumor’s aggressive nature.
• Diagnostics: the authors highlight both difficulties (nonspecific signs, late presentation) and possibilities (tools and approaches that can lead to diagnosis) in clinical practice.

Clinical picture: how affected horses typically present

• Dominant sign: chronic, sometimes marked weight loss and poor body condition despite adequate management.
• Additional signs (commonly reported in such cases): reduced appetite, intermittent mild colic, lethargy, and occasionally signs consistent with gastric pain (e.g., bruxism or salivation) due to ulcerated tumor surfaces.
• Systemic effects: chronic disease can lead to anemia, hypoproteinemia (with possible ventral edema), and cachexia.
• Course: gradual progression over weeks to months, often without dramatic acute episodes until late disease.

Pathology overview (context for interpretation)

• Origin: arises from the squamous (nonglandular) mucosa of the equine stomach, commonly near the margo plicatus.
• Gross appearance: proliferative or ulcerative masses that may bleed, erode, or obstruct gastric outflow; surfaces may be friable or cauliflower-like.
• Microscopic features: nests and cords of atypical squamous cells with keratinization (keratin pearls) and intercellular bridges infiltrating the gastric wall.
• Spread: frequent metastasis to regional lymph nodes, liver, spleen, diaphragm, lungs, and/or peritoneal seeding; this aligns with the abstract’s note that metastases had often developed.
• Consequences: ulceration and bleeding contribute to anemia; infiltration and spread drive systemic decline and weight loss.

Diagnosis: difficulties and practical options

• Why it’s hard:
  • Clinical signs (weight loss, inappetence, intermittent colic) are nonspecific and overlap with common conditions (e.g., gastric ulcer disease, dental problems, parasitism, malabsorption, lymphoma).
  • Tumors may be large or ulcerated yet not easily visualized if feed obscures the stomach or the lesion is beyond the field of view.
  • Routine bloodwork changes (anemia of chronic disease, hypoalbuminemia, inflammatory leukogram) are supportive but not diagnostic.
• What can help:
  • Gastroscopy with adequate fasting (and a sufficiently long endoscope) to visualize the squamous region and obtain targeted biopsies of suspicious masses or ulcerative lesions.
  • Abdominal ultrasound to detect gastric wall thickening, peritoneal effusion, or hepatic and lymph node metastases.
  • Abdominocentesis when effusion is present; cytology may occasionally reveal neoplastic cells or inflammatory changes suggestive of tumor seeding.
  • Cross-sectional imaging or diagnostic laparoscopy in select cases where available, to assess extent and sample lesions.
  • Definitive diagnosis rests on histopathology of biopsied tissue or necropsy specimens.
• Suggested approach in practice:
  • Maintain a differential for gastric SCC in mature horses with unexplained, progressive weight loss and poor condition.
  • Prioritize early gastroscopy and abdominal ultrasound; if initial evaluations are inconclusive but suspicion remains, re-scope after more rigorous feed withholding and consider alternative sampling methods.
  • Stage for metastasis (especially liver and regional nodes) once a gastric mass is identified, to guide prognosis and decision-making.

Management and prognosis (context beyond the abstract)

• Treatment options are limited; complete surgical excision is rarely feasible due to tumor location and late detection.
• Systemic chemotherapy protocols are not established in horses for this tumor type; palliative care (analgesia, acid suppression, dietary modification) may provide short-term comfort.
• Prognosis is generally poor when metastases are present or the mass is large; many cases culminate in euthanasia on welfare grounds.

What this case series adds

• Reinforces that equine gastric SCC can affect adult horses as young as six years and often presents primarily as weight and condition loss.
• Highlights the frequency of metastasis at the time of recognition, emphasizing the need for early consideration and thorough diagnostic workups.
• Underscores practical diagnostic hurdles and points clinicians toward endoscopy, imaging, and histopathology as key tools.

Limitations to consider

• Small sample size (n = 7) limits generalizability and prevents estimation of incidence or risk factors.
• Likely referral and necropsy bias toward more advanced cases with metastasis.
• Descriptive design without controls or standardized diagnostic protocols.

Practical takeaways for veterinarians

• Include gastric SCC in the differential diagnosis for mature horses with chronic, unexplained weight loss and declining condition.
• Use early gastroscopy (with adequate feed withholding) and abdominal ultrasound to look for a gastric mass and metastases.
• Confirm diagnosis with biopsy and histopathology when possible, and stage to inform prognosis and client counseling.
• Prepare owners for a guarded to poor prognosis, especially if metastases are identified or the lesion is extensive.